288 related articles for article (PubMed ID: 8140499)
1. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
2. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
3. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
5. [All-trans retinoic acid therapy in acute promyelocytic leukemia--current status and prospect].
Kitamura K; Takeshita A; Ono R; Naoe T
Rinsho Ketsueki; 1996 Sep; 37(9):760-5. PubMed ID: 8914458
[No Abstract] [Full Text] [Related]
6. On the differentiative mode of action of All-trans retinoic acid in acute promyelocytic leukemia.
Lo Coco F; Diverio D; Avvisati G; Mandelli F; Biondi A; Pelicci PG
Blood; 1995 Oct; 86(8):3264-5. PubMed ID: 7579425
[No Abstract] [Full Text] [Related]
7. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia: from genetics to treatment.
Grignani F; Fagioli M; Alcalay M; Longo L; Pandolfi PP; Donti E; Biondi A; Lo Coco F; Grignani F; Pelicci PG
Blood; 1994 Jan; 83(1):10-25. PubMed ID: 8274729
[No Abstract] [Full Text] [Related]
9. Differentiation therapy of acute promyelocytic leukemia: clinical and molecular features.
Miller WH
Cancer Invest; 1996; 14(2):142-50. PubMed ID: 8597899
[No Abstract] [Full Text] [Related]
10. [Treatment for acute promyelocytic leukemia].
Fujita H
Rinsho Ketsueki; 2014 Oct; 55(10):1817-26. PubMed ID: 25297745
[No Abstract] [Full Text] [Related]
11. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
12. FISH-negative, cytogenetically cryptic acute promyelocytic leukemia.
Rashidi A; Fisher SI
Blood Cancer J; 2015 Jun; 5(6):e320. PubMed ID: 26090620
[No Abstract] [Full Text] [Related]
13. [Arsenic and retinoic acid, toward targeted treatments of acute promyelocytic anemia?].
de Thé H
C R Seances Soc Biol Fil; 1998; 192(2):273-81. PubMed ID: 9759370
[TBL] [Abstract][Full Text] [Related]
14. Genetics of APL and the molecular basis of retinoic acid treatment.
Casini T; Grignani F; Pelicci PG
Int J Cancer; 1997 Feb; 70(4):473-4. PubMed ID: 9033658
[No Abstract] [Full Text] [Related]
15. Probing the pathobiology of response to all-trans retinoic acid in acute promyelocytic leukemia: premature chromosome condensation/fluorescence in situ hybridization analysis.
Vyas RC; Frankel SR; Agbor P; Miller WH; Warrell RP; Hittelman WN
Blood; 1996 Jan; 87(1):218-26. PubMed ID: 8547645
[TBL] [Abstract][Full Text] [Related]
16. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid.
Mazharuddin S; Chattopadhyay A; Levy MY; Redner RL
Leuk Lymphoma; 2018 Sep; 59(9):2246-2249. PubMed ID: 29350080
[No Abstract] [Full Text] [Related]
17. Delayed or insufficient restoration of PML and PML-RAR alpha subcellular localization after exposure in vitro to retinoic acids in all-trans retinoic acid-resistant APL cells.
Naoe T; Yoshida H; Kitamura K; Chino M; Osumi K; Ohno R
Leukemia; 1995 Sep; 9(9):1610-1. PubMed ID: 7658735
[No Abstract] [Full Text] [Related]
18. CNS relapse in acute promyeloctyic leukemia.
Housman E; Chang P; Lane SW; Blinder R; Galinsky I; Kesari S; Ho VT; Stone RM; Mullally A
J Clin Oncol; 2010 Aug; 28(24):e409-11. PubMed ID: 20530270
[No Abstract] [Full Text] [Related]
19. Role of the promyelocytic leukaemia protein in cell death regulation.
Salomoni P; Dvorkina M; Michod D
Cell Death Dis; 2012 Jan; 3(1):e247. PubMed ID: 22237204
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
